tert-Butyl (1R*,4R*)-4-(4-methoxybenzylamino)cyclohexylcarbamate, 1g

2,3-Dimethylmaleic anhydride, 98.0%, 10g

2,5-Dihydroxyterephthalic acid, 95.0%, 5g

Methyl 2-((tert-butoxycarbonyl)amino)pent-4-enoate, 98%, 1g

Veralipride>98.0%(T)(HPLC)10mg

4-Hydroxy-1,5-naphthyridine, 95.0%, 250mg

4-PHENYL-1,2,5-THIADIAZOLE-3-CARBOXYLIC ACID, 95.0%, 1g

3-Bromo-2,4,6-trimethylbenzoic acid, 97%, 500mg

2-Chloro-6-methoxynicotinaldehyde, 95.0%, 5g

(2E)-1-(4-bromophenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

tert-butyl 4-(piperidin-3-ylmethyl)piperazine-1-carboxylate, 97.0%, 1g

methyl 3-methylbenzoate, 95.0%, 25g

n-Hexane, ROTIDRY®Sept, min 99 % (min 30 ppm H2O), 250 ml, flacon septum